Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences IncCSTL · filed Sep 1, 2026

Accession no.
0001628280-26-059816
Filed
Sep 1, 2026, 4:12 PM ET
Trade date
Aug 28, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $616.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 28, 2026Common StockMOption exerciseAcquired+12,428$2.39+$29,702.9233,907Direct
Aug 28, 2026Common StockSSaleDisposed−11,472$33.14F2−$380,182.0822,435Direct
Aug 28, 2026Common StockSSaleDisposed−2,505$33.14F2−$83,015.717,850Indirect
Aug 28, 2026Common StockSSaleDisposed−2,129$33.14F2−$70,555.0615,172Indirect
Aug 28, 2026Common StockSSaleDisposed−257$33.14F2−$8,516.9811,277Indirect
Aug 28, 2026Common StockSSaleDisposed−257$33.14F2−$8,516.9811,277Indirect
Aug 28, 2026Common StockSSaleDisposed−257$33.14F2−$8,516.9811,277Indirect
Aug 28, 2026Common StockSSaleDisposed−257$33.14F2−$8,516.9811,277Indirect
Aug 28, 2026Common StockSSaleDisposed−956$33.88F9−$32,389.2821,479Direct
Aug 28, 2026Common StockSSaleDisposed−209$33.88F9−$7,080.9217,641Indirect
Aug 28, 2026Common StockSSaleDisposed−177$33.88F9−$5,996.7614,995Indirect
Aug 28, 2026Common StockSSaleDisposed−21$33.88F9−$711.4811,256Indirect
Aug 28, 2026Common StockSSaleDisposed−21$33.88F9−$711.4811,256Indirect
Aug 28, 2026Common StockSSaleDisposed−21$33.88F9−$711.4811,256Indirect
Aug 28, 2026Common StockSSaleDisposed−21$33.88F9−$711.4811,256Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 28, 2026Common StockMOption exerciseDisposed−12,428$0.00$025,329Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $32.78 to $33.70, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $33.78 to $33.97, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)